References
- M. Uguccioni, M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini, "Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes", Eur. J. Immunol., Vol. 25, pp. 64-68, 1995. https://doi.org/10.1002/eji.1830250113
- R. W. Chapman, J. E. Phillips, R. W. Hipkin, A. K. Curran, D. Lundell, and J. S. Fine, "CXCR2 antagonists for the treatment of pulmonary disease", Pharmacol. Therapeut., Vol. 212, pp. 55-68, 2009.
- J. Reutershan, A. Basit, E. V. Galkina, and K. Ley, "Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced lung injury", Am. J. Physiol-Lung C., Vol. 289, pp. L807-L815, 2005. https://doi.org/10.1152/ajplung.00477.2004
- S. L. Traves, S. J. Smith, P. J. Barnes, and L. E. Donnelly, "Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2", J. Leukocyte. Biol., Vol. 76, pp. 441-450, 2004. https://doi.org/10.1189/jlb.1003495
- K. J.Eash, A. M. Greenbaum, P. K. Gopalan, and D. C. Link, "CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow", J. Clin. Invest., Vol. 120, pp. 2423-2431, 2010. https://doi.org/10.1172/JCI41649
- R. A. Pauwels and K. F. Rabe, "Burden and clinical features of chronic obstructive pulmonary disease (COPD)", Lancet, Vol. 364, pp. 613-620, 2004. https://doi.org/10.1016/S0140-6736(04)16855-4
- E. H. Bel, A. Sousa, L. Fleming, A. Bush, K. F Chung, J. Versnel, A. H. Wagener, S. S. Wagers, P. J. Sterk, and C. H. Compton, "Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)", Thorax, 2010.
- P. Anderson, "Emerging therapies in cystic fibrosis", Ther. Adv. Respir. Dis., Vol. 4, pp. 177-185, 2010. https://doi.org/10.1177/1753465810371107
- P. M. Murphy, "Neutrophil receptors for interleukin-8 and related CXC chemokines", Semin. Hematol., Vol. 34, pp. 311-318, 1997.
- W. Sippl, "3D-QSAR - Applications, recent advances, and limitations", in Recent Advances in QSAR Studies: Methods and Applications, Heidelberg: Springer, 2010
- B. Sathya and M. Thirumurthy, "Pharmacophore based comparative molecular field analysis of CRTh2 antagonists", J. Chosun Natural Sci., Vol. 8, pp. 89-98, 2015. https://doi.org/10.13160/ricns.2015.8.2.89
- B. Sathya and M. Thirumurthy, "Comparative molecular field analysis of caspase-3 inhibitors", J. Chosun Natural Sci., Vol. 7, pp. 166-172, 2014. https://doi.org/10.13160/ricns.2014.7.3.166
- M. Thirumurthy, "Modeling aided lead design of FAK inhibitors", J. Chosun Natural Sci., Vol. 4, pp. 266-272, 2011.
- M. Thirumurthy, "3D-QSAR studies of 3,5-disubstituted quinolines inhibitors of c-Jun N-terminal kinase-3", J. Chosun Natural Sci., Vol. 4, pp. 216-221, 2011.
- D. W. Porter , M. Bradley, Z. Brown, S. J. Charlton, B. Cox, P. Hunt, D. Janus, S. Lewis, P. Oakley, D. O'Connor, J. Reilly, N. Smith, and N. J. Press, "The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists", Bioorg. Med. Chem. Lett., Vol. 24, pp. 3285-3290, 2014. https://doi.org/10.1016/j.bmcl.2014.06.011
- SYBYL Software, Version X 2.0., 2006, Tripos Associates Inc, St. Louis, USA.
- G. Klebe, U. Abraham, and T. Mietzner, "Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity", J. Med. Chem., Vol. 37, pp. 4130-4146, 1994. https://doi.org/10.1021/jm00050a010
- S. Wold, A. Ruhe, H. Wold, and W. J. Dunn, "The collinearity problem in linear-regression- the partial least squares (PLS) approach to generalized inverses", SIAM Journal on Scientific and Statistical Computing, Vol. 5, pp. 735-743, 1984. https://doi.org/10.1137/0905052
- S. Wold, "Cross-validatory estimation of the number of components in factor and principal component model", Technometrics, Vol. 20, pp. 397-405, 1978. https://doi.org/10.1080/00401706.1978.10489693